Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IRENE MORAE KANG

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1336430727
CMS profile
1328730
Location
IRVINE, CA

General Payments · PY2018–2024

$54,426.98

  • Reported across 127 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$20,412.77

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $9,311.57 12
Gilead Sciences, Inc. $4,382.21 11
Stemline Therapeutics Inc. $3,120.00 2
NOVARTIS PHARMACEUTICALS CORPORATION $2,069.15 2
PFIZER INC. $1,392.69 2
Amgen Inc. $79.60 1
Acerta Pharma LLC $29.43 1
ABBVIE INC. $28.12 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $6,966.78 34
PY2019 $13,774.08 32
PY2020 $8,047.92 12
PY2021 $2,609.06 3
PY2022 $670.82 2
PY2023 $1,945.55 12
PY2024 $20,412.77 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $28.12 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104027485 CMS
Amgen Inc. $79.60 11/04/2024 Food and Beverage Undisputed 01/23/2026 1111613763 CMS
AstraZeneca Pharmaceuticals LP $29.43 12/12/2024 Food and Beverage Undisputed 01/23/2026 1104715953 CMS
Daiichi Sankyo Inc. $2,350.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1089440173 CMS
Daiichi Sankyo Inc. $235.00 03/13/2024 Consulting Fee Undisputed 01/23/2026 1089440159 CMS
Daiichi Sankyo Inc. $1,880.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1089440155 CMS
Daiichi Sankyo Inc. $705.00 06/19/2024 Consulting Fee Undisputed 01/23/2026 1089440171 CMS
Daiichi Sankyo Inc. $470.00 07/24/2024 Consulting Fee Undisputed 01/23/2026 1089440163 CMS
Daiichi Sankyo Inc. $705.00 08/28/2024 Consulting Fee Undisputed 01/23/2026 1089440165 CMS
Daiichi Sankyo Inc. $1,387.50 09/04/2024 Consulting Fee Undisputed 01/23/2026 1089440153 CMS
Daiichi Sankyo Inc. $235.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1089440161 CMS
Daiichi Sankyo Inc. $138.75 10/24/2024 Consulting Fee Undisputed 01/23/2026 1089440169 CMS
Daiichi Sankyo Inc. $940.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1089440167 CMS
Daiichi Sankyo Inc. $235.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1089440157 CMS
Daiichi Sankyo Inc. $30.32 12/12/2024 Food and Beverage Undisputed 01/23/2026 1089440151 CMS
Gilead Sciences, Inc. $23.86 02/07/2024 Food and Beverage Undisputed 01/23/2026 1133833310 CMS
Gilead Sciences, Inc. $3,320.00 03/06/2024 Consulting Fee Undisputed 01/23/2026 1133600157 CMS
Gilead Sciences, Inc. $420.00 04/19/2024 Consulting Fee Undisputed 01/23/2026 1133600159 CMS
Gilead Sciences, Inc. $39.60 06/25/2024 Food and Beverage Undisputed 01/23/2026 1133833312 CMS
Gilead Sciences, Inc. $105.92 08/01/2024 Food and Beverage Undisputed 01/23/2026 1133833314 CMS
Gilead Sciences, Inc. $130.72 08/23/2024 Food and Beverage Undisputed 01/23/2026 1133833316 CMS
Gilead Sciences, Inc. $28.08 09/24/2024 Food and Beverage Undisputed 01/23/2026 1133833318 CMS
Gilead Sciences, Inc. $117.31 11/09/2024 Food and Beverage Undisputed 01/23/2026 1133833320 CMS
Gilead Sciences, Inc. $28.34 12/11/2024 Food and Beverage Undisputed 01/23/2026 1133833322 CMS
Gilead Sciences, Inc. $54.86 12/11/2024 Food and Beverage Undisputed 01/23/2026 1133833324 CMS
Gilead Sciences, Inc. $113.52 12/12/2024 Food and Beverage Undisputed 01/23/2026 1133833326 CMS
Novartis Pharmaceuticals Corporation $2,025.00 11/04/2024 Consulting Fee Undisputed 01/23/2026 1087121058 CMS
Novartis Pharmaceuticals Corporation $44.15 12/11/2024 Food and Beverage Undisputed 01/23/2026 1087121056 CMS
PFIZER INC. $1,262.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1132015511 CMS
PFIZER INC. $130.69 08/23/2024 Food and Beverage Undisputed 01/23/2026 1131364620 CMS
Stemline Therapeutics Inc. $1,950.00 09/13/2024 Consulting Fee Undisputed 01/23/2026 1142960469 CMS
Stemline Therapeutics Inc. $1,170.00 10/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1142960467 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.